7-day free trial: Get unlimited comparisons, and stock, ETF and mutual fund analyses for just $15/month, without ads. Start a trial. Go ad free!
BBH vs ARKG
Both ARKG and BBH are ETFs. ARKG has a higher 5-year return than BBH (45.99% vs 11.13%). ARKG has a higher expense ratio than BBH (0.75% vs 0.35%). Below is the comparison between ARKG and BBH.
| ARKG | BBH | |
|---|---|---|
| Segment | Equity: Global Biotech | Equity: Global Biotech |
| Issuer | ARK | VanEck |
| Net Assets | $7.65B | $478.8M |
| Expense Ratio | 0.75% | 0.35% |
| Management Style | active | passive (index-based) |
| Dividend Yield | 0.85% | 0.36% |
| Underlying Index | -- | MVIS US Listed Biotech 25 Index |
| YTD Return | 15.76% | 6.65% |
| 1-Year Return | 209.63% | 29.43% |
| 3-Year Return | 64.53% | 12.34% |
| 5-Year Return | 45.99% | 11.13% |
| 10-Year Return | N/A | N/A |
ARKG description
The Fund seeks long-term growth of capital. The Fund is an actively-managed exchange-traded fund that will invest under normal circumstances primarily in domestic and foreign equity securities of companies across multiple sectors, including healthcare, information technology, materials, energy and consumer discretionary.
ARKG performance & returns
| YTD Return | 15.76% |
| 1-Month Return | 14.98% |
| 3-Month Return | 49.30% |
| 1-Year Return | 209.63% |
| 3-Year Return | 64.53% |
| 5-Year Return | 45.99% |
| 10-Year Return | N/A |
ARKG expense ratio is 0.75%.
ARKG holdings
Top 10 Holdings (52.77% of Total Assets)
| Name | Symbol | % Assets |
|---|---|---|
| Invitae Corp | NVTA | 8.84% |
| CRISPR Therapeutics AG | CRSP | 8.44% |
| Pacific Biosciences of California Inc | PACB | 7.19% |
| Arcturus Therapeutics Holdings Inc | ARCT | 5.75% |
| Twist Bioscience Corp | TWST | 4.61% |
| CareDx Inc | CDNA | 3.89% |
| Iovance Biotherapeutics Inc | IOVA | 3.76% |
| Personalis Inc | PSNL | 3.50% |
| Exact Sciences Corp | EXAS | 3.41% |
| Seres Therapeutics Inc | MCRB | 3.38% |
Other relevant ARKG comparisons
You may also want to check out the following ARKG comparisons that investors often look for on Finny
Or use Finny Compare Wizard to create a comparison you’d like to see.
BBH description
The Fund seeks to replicate the price and yield performance of the Market Vectors US Listed Biotech 25 Index. The Index is comprised of common stocks and depository receipts of US exchange-listed companies in biotechnology sector.
BBH performance & returns
| YTD Return | 6.65% |
| 1-Month Return | 3.82% |
| 3-Month Return | 11.59% |
| 1-Year Return | 29.43% |
| 3-Year Return | 12.34% |
| 5-Year Return | 11.13% |
| 10-Year Return | N/A |
BBH expense ratio is 0.35%.
BBH holdings
Top 10 Holdings (61.45% of Total Assets)
| Name | Symbol | % Assets |
|---|---|---|
| Amgen Inc | AMGN | 14.27% |
| Gilead Sciences Inc | GILD | 7.23% |
| Moderna Inc | MRNA | 5.48% |
| Regeneron Pharmaceuticals Inc | REGN | 5.47% |
| Exact Sciences Corp | EXAS | 5.28% |
| Alexion Pharmaceuticals Inc | ALXN | 4.92% |
| IQVIA Holdings Inc | IQV | 4.91% |
| Biogen Inc | BIIB | 4.75% |
| Vertex Pharmaceuticals Inc | VRTX | 4.59% |
| Illumina Inc | ILMN | 4.55% |
Other relevant BBH comparisons
You may also want to check out the following BBH comparisons that investors often look for on Finny
Or use Finny Compare Wizard to create a comparison you’d like to see.
You can check out all comparisons Finny users have looked for here. Feel free to the browse the list and view the comparisons that are of an interest to you.
